We are live on ! Find out more
GRTS

Gritstone bio, Inc. Common Stock

Delisted

GRTS was delisted on the 21st of October, 2024.

6 hedge funds and large institutions have $773 invested in Gritstone bio, Inc. Common Stock in 2024 Q4 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 50 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 2

89% less funds holding

Funds holding: 566 (-50)

98% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 50

100% less funds holding in top 10

Funds holding in top 10: 10 (-1)

100% less capital invested

Capital invested by funds: $20.7M → $773 (-$20.7M)

Holders
6
Holders Change
-50
Holders Change %
-89.29%
% of All Funds
0.08%
Holding in Top 10
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-100%
% of All Funds
New
1
Increased
1
Reduced
2
Closed
50
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
Citigroup
51
Citigroup
New York
-$82 -142 Closed
AF
52
Allworth Financial
California
-$58 -100 Closed
Northwestern Mutual Wealth Management
53
Northwestern Mutual Wealth Management
Wisconsin
-$58 -100 Closed
PD
54
Point72 (DIFC)
United Arab Emirates
-$40 -69 Closed
Simplex Trading
55
Simplex Trading
Illinois
+$3.31K +27,112 +158%

GRTS Hedge Fund Activity: Q4 2024 in Review

6 of the 7,593 institutional investors tracked by Wall St. Rank reported a position in Gritstone bio, Inc. Common Stock (GRTS) for Q4 2024, worth a combined $773 — down 100% from $20.7M a quarter earlier.

Sellers outnumbered buyers: 50 funds closed out of GRTS and 1 opened new positions — a net loss of 49 holders — while 2 trimmed existing stakes and 1 added.

The largest buyer was Baader Bank Aktiengesellschaft, opening a new position worth an estimated $8.19K. The largest seller was Morgan Stanley, exiting entirely with an estimated $5.97M sold.

  • 6 institutional investors held Gritstone bio, Inc. Common Stock (GRTS) as of Q4 2024, down from 56 in Q3 2024.
  • Funds reported $773 of Gritstone bio, Inc. Common Stock stock for Q4 2024, down 100% quarter-over-quarter.
  • 1 fund opened new Gritstone bio, Inc. Common Stock positions in Q4 2024 and 50 closed out, a net change of -49 holders.
  • The largest Gritstone bio, Inc. Common Stock buyer in Q4 2024 was Baader Bank Aktiengesellschaft, an estimated $8.19K added.
  • The largest Gritstone bio, Inc. Common Stock seller in Q4 2024 was Morgan Stanley, an estimated $5.97M sold.

Based on aggregated 13F filings for Q4 2024.